Florian Heil
- Immunology top 0.5%
- Immune Response and Inflammation 2
- Microbiology top 2%
- Virology top 5%
- Cancer Research top 5%
- Oncology top 5%
- Cancer Cells and Metastasis 2
-
- Glycosylation and Glycoproteins Research 3
- Angiogenesis and VEGF in Cancer 3
-
- Proteoglycans and glycosaminoglycans research 3
-
- Sarcoma Diagnosis and Treatment 2
-
- Monoclonal and Polyclonal Antibodies Research 2
-
- Lymphoma Diagnosis and Treatment 2
- Co-authors
- Stefan BauerGrayson B. LipfordHubertus HochreinHermann WagnerFranziska AmpenbergerHiroaki HemmiShizuo AkiraCarsten J. Kirschning
- Cited by
- ImmunologyMicrobiologyVirology
- Journals
- Clinical Cancer Research (1 paper)Frontiers in Oncology (1 paper)Translational Oncology (1 paper)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Florian Heil
11 papers receiving 4.0k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Immunology 2.8k
- Microbiology 277
- Virology 197
- Cancer Research 479
- Oncology 606
Countries citing papers authored by Florian Heil
This map shows the geographic impact of Florian Heil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florian Heil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florian Heil more than expected).
Fields of papers citing papers by Florian Heil
This network shows the impact of papers produced by Florian Heil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florian Heil. The network helps show where Florian Heil may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Florian Heil, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 8 | |
| 2 | 2020 | 14 | |
| 3 | 2020 | 4 | |
| 4 | 2018 | 16 | |
| 5 | 2017 | 6 | |
| 6 | 2016 | 113 | |
| 7 | 2015 | 45 | |
| 8 | Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism studybreakdown → | 2012 | 455 |
| 9 | 2011 | 10 | |
| 10 | Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8breakdown → | 2004 | 3049 |
| 11 | 2003 | 406 |
About Florian Heil
Florian Heil is a scholar working on Oncology, Cell Biology, Microbiology, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 11 papers that have together received 4.1k indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (3 papers), Angiogenesis and VEGF in Cancer (3 papers), Proteoglycans and glycosaminoglycans research (3 papers), Sarcoma Diagnosis and Treatment (2 papers), Immune Response and Inflammation (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Lymphoma Diagnosis and Treatment (2 papers) and Cancer Cells and Metastasis (2 papers). The work is most often cited by research in Immunology (2.8k citations), Microbiology (277 citations), Virology (197 citations), Cancer Research (479 citations) and Oncology (606 citations). Florian Heil has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Stefan Bauer, Grayson B. Lipford, Hubertus Hochrein, Hermann Wagner, Franziska Ampenberger, Hiroaki Hemmi, Shizuo Akira, Carsten J. Kirschning, Parviz Ahmad‐Nejad and Kiyoshi Takeda. Their work appears in journals such as Clinical Cancer Research, Frontiers in Oncology, Translational Oncology, Science and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.